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An investment model for the lifetime analysis of capital
investments, for example instruments, in the clinical chemistry
laboratory has been developed. All costs have been considered in
relation to the actual time they were incurred. Based on the criterion
ofminimal costsfor clinical chemistry tests, the economic lifetime of
investments can be estimated. The model described can be an
important tool in laboratory management and a great help in
discussions about the allocation of financial resources. The model is
applicable to every laboratory.
Introduction
A lot of attention is paid today to the cost of clinical
chemistry tests. The policy-makers in the health services,
the health insurance companies and the managers and
directors of hospitals and institutions are regularly cited
by the news media about their concern with regard to the
inflation in the costs of, among other things, laboratory
tests. Many studies have been published on the question
of the cost of clinical chemistry tests 1-5]. However, in
those studies the question of determining the economic
lifetime of investments is not often dealt with in any
detail. In practice such investments are included in the
cost of clinical chemistry tests without analysing the
economic lifetime.
In the present paper the financial basis for purchasing
clinical chemistry instruments is determined in a gener-
ally applicable investment model, On the grounds of
prospective data and the application of the criterion of
minimal costs, the lifetime ofan analysis instrument, which
one might wish to purchase, can be estimated. The results
of the model can be adjusted in retrospect to the actual cost
of developments. In this model the cost at particular
times can be compared using the well-known- in the field
of business administration- discounting method [6 and
7].
Investment selection, lifetime analysis and deprecia-
tion
Basically, the problem of investing in fixed assets is no
different from investing in floating means of production.
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Fixed assets (durable means of production) should be
interpreted as assets, whereby the application can be
attributed to successive production processes. One of the
most difficult problems in ascribing the fixed assets to
several production processes is the fact that depreciation
of the assets often does not lie in an objectively
demonstrable relationship with the application in one
production process. Deduced from the method ofapplica-
tion, the investment and other expenses ofthe fixed assets
are divided over successive production processes and
usually over several years.
There are a number of reasons why investing in fixed
assets differs from investing in floating assets. In the first
place, time plays a much greater part in investments in
durable means ofproduction (fixed assets) than it does in
floating means ofproduction. Secondly, there are produc-
tion/technical connections of means of production. Dur-
able means of production will generally only be produc-
tive in combination with other production factors, such as
labour and raw materials. These production factors
should be considered as a conglomeration (unit) and not
as a random collection. The achievements of durable
means ofproduction are therefore considered to be part of
a unit. In the selection of investments an estimation is
made beforehand ofthe possible combinations ofproduc-
tion factors which will result in the lowest cost over the
total lifetime. It is, ofcourse, logical that the price per unit
product in this context-is considered over the whole
lifetime.
In an investment project it is necessary to consider the
total investment made in associated durable means of
production and all additional investments in floating
assets (such as, for example, stocks of reagents and
disposables).
Principles from business management, for example the
average accountable productiveness, the return-on-
investment period and the internal productiveness, are
used to choose the most profitable investment project and
are not applied in the determination of the economic
lifetime ofa durable means ofproduction. They are often
used in connection with the economic lifetime, but do not
form a judgement about it. This often gives rise to
confusion.
The technical lifetime of an analysis instrument is the
period of time that the instrument is technically capable
ofconducting the activities for which it was purchased. In
determining the economic lifetime, the deciding factor is
the period of time over which it is considered to be
economically worthwhile to use the instrument. The
economic lifetime of a durable means of production is
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determined via various factors, partly by factors which
are inherent to technical functioning (wear and servicing)
and partly by the economic and technical circumstances
(for example changes in the requested capacity and the
availability ofcompetitive means ofproduction which are
cheaper, safer or cleaner in their application).
In a clinical chemistry laboratory, production takes place
through a combination of different means of production
(labour, raw materials and analysis instruments). De-
preciation and interest over the capital invested are fixed
costs. All the other costs which are necessary for the
production are called complementary costs in the investment
model presented here. The complementary costs include
the exploitation costs, such as labour and raw materials,
and the service costs ofthe investment. As a consequence,
depreciation and interest, together with the complemen-
tary costs, form the total cost of the production.
The investment model
In the investment model the criterion used to determine
the optimal economic lifetime ofa fixed production factor
is chosen as the number ofyears in which the average cost
price of the product is minimal. All the costs of the
investment project are estimated in advance, so it is
possible to calculate a price per product. In theory this
price could also be used as the cost price.
The following assumptions are made in the application of
this criterion"
(1) The expected development of the technique is nil (as
soon as this changes strongly in reality, this develop-
ment is immediately taken into account in the
model and it is subsequently assumed that the
development of the technique is constant).
(2) The present analysis process is continued at the same
quantity ofproduction for an indefinite period oftime
(as soon as the production quantities increase or
decrease, this modification is incorporated in the
model).
(3) The prices of the remaining production factors (such
as labour and raw materials) stay unchanged.
It is only possible to determine the way in which
depreciation of an analysis instrument takes place when
its lifetime has come to an end. However, due to the fact
that depreciation should be included in the cost price of
laboratory investigations during use, it is necessary to
make a prognosis of the way in which depreciation will
occur as soon as the analysis instrument is put to use. If it
appears that depreciation runs a different course during
the period ofuse then the prognosis must be amended in
the investment model.
As a result of the choice ofa criterion: the same cost price
for the whole period of use (as a guideline to specify the
known costs), the basis for the depreciation plan in the
investment model is determined by the condition that the
sum of the complementary costs, depreciation and
interest is constant assuming constant quantities of
production. The choice did not fall on the potentially
more applicable depreciation plan, in which the purchase
price of the analytical instrument is divided over the
expected period of use, taking the residual values into
account (linear and book value depreciation systems). In
the chosen depreciation method the same costs are
calculated for equal performances regardless of the year
in which these performances take place. The total costs of
the analysis instrument (complementary costs, deprecia-
tion and interest) are divided over the number ofyears of
use in proportion to the number ofperformances per year.
In practice it is common, after a certain period ofuse ofan
analytical instrument, for an alternative opportunity to
arise where the same laboratory tests can be done for a
lower cost price. This can now lead to a shortening or the
end of the economic lifetime of the instrument which is
being used- the value of the analytical instrument
decreases or elapses due to technical developments. The
moment at which the existing instrument should be
replaced can be determined with the aid ofthe investment
model.
The investment model is used to calculate the financial
consequences of investment alternatives to support de-
cision-making. It speaks for itself that in the question of
purchase and replacement of analysis instruments other
aspects must also be taken into consideration. Aspects
such as the quality of clinical chemistry tests and of the
provision of services, the influence of waste products on
the environment and the ease ofuse and service grade are
difficult to define in cost terms.
The construction of the model
The first step in the construction ofthe model requires the
following financial data to be collected:
(1) The sum to be invested (purchase price of the
instrument, including installation and training
costs).
2) The percentage of interest, to calculate the loss of
investment opportunities.
(3) The variable exploitation costs per unit product
(costs of chemicals and labour per test or request).
(4) The production quantities (the number of tests or
requests per year) and the technical lifetime of the
instrument. The remaining complementary costs per
year, i.e. the fixed exploitation costs, must also be
estimated. These include service and maintenance
charges (labour and materials), and the costs of the
loss of capacity due to breakdown (extra labour and
raw materials). If necessary, these costs can be
estimated prospectively on the basis ofexperience with
similar instruments.
Ifit appears that estimates are not accurate after a certain
period of use, the model must be refilled with data
retrospectively. This may give rise to a different cost price,
and, in some cases, a decision to replace the instrument.
In principle it is assumed that the residual value of the
analytical instrument to be purchased is nil when the
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technical lifetime has elapsed. However, residual value
can be taken into account in the investment model.
Costs which have been estimated at different times
cannot be compared without further processing. They
can be made comparable (and added together) after
correction for the time difference, by calculating their cash
value. In the investment model all expenses for com-
plementary costs are made comparable to the expenses
for the purchase of the instrument through conversion to
the beginning of the first year of use (moment of
purchase), according to the discounting method, in which
the annuity is calculated. To do this it is necessary to know
the amount of interest that will be lost.
The sum invested augmented by the cash value of the
complementary costs of each year of use, results in the
cash value of the total costs at the beginning of the
investment. Due to the arithmetical assumption in the
investment model that all products have been delivered at
the end of each year, it is necessary to divide the total
amount of costs equally over a number of years’ use with
the aid of the discounting method. The resulting amount,
divided by the production quantities, results in the cost
price per test or request. The application of the criterion
of the minimal costs determines the economic lifetime.
In a clinical chemistry laboratory the products (i.e. test
results) are delivered daily rather than annually. The
investment model does not enter further into such
specification, because, in essence, the results remain
unchanged and consequently no extra information is
supplied. In theory the model can be filled with data
relating to a period of less than one year (and thus also to
one day, for instance); for practical reasons this is,
however, not very advisable for comparisons between
potential purchases.
From the economic lifetime and the associated average
costs per year calculated in this way, the system of
depreciation can be determined. The basis of the system
ofdepreciation is formed by the condition that the sum of
the complementary costs, depreciation and interest is
constant. This means that the average annual costs, less
the complementary costs, result in the total amount
available for interest and depreciation (to preserve the
calculated minimal cost price). Depreciation is subse-
quently calculated by subtracting the interest over the
book value ofthe instrument at the beginning ofeach year
of use from the total amount available for interest and
depreciation.
An example of an investment
In this example the economic lifetime, depreciation and
interest are calculated for a (fictitious) analytical instru-
ment with the aid of the investment model.
It is assumed that the purchase price of an instrument is
15 000 Dutch guilders (Dfl.). The production quantity is
1000 tests per year. The technical lifetime is five years.
The residual value ofthe instrument is nil. The interest is
10%.
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Table 1. Calculation of the economic lifetime of a fictitious
analysis instrument on the basis ofthe criterion ofminimal costs.
All prices shown are in Dutch guilders. The lifetime in years is




Cash value Cost price
complementary Cash value per unit
costs total costs product per
years to 5 years to 5 year
(3) (4) (5)
15 000 10 909 25 909 28"50
2 15000 21 653 36653 21"12
3 15000 32547 47547 19"12
4 15 000 44 158 59 158 18"66
5 15 000 56 577 71 577 18.88
The complementary costs, including the variable exploi-
tation costs for a production of 1000 tests per year, in the
successive years of use are considered to be made at the
end of each year. The course is as follows:
Year 1- Dfl. 12 000
Year 2 Dfl. 13 000
Year 3 Dfl. 14 500
Year 4- Dfl. 17 000
Year 5- Dfl. 20 000
The calculation for estimating the economic lifetime,
based on the criterion ofminimal costs, is shown in table
1.
In column 2 the total debit is shown for the use of the
analysis instrument over one, two, three, four or five
years. Since it is assumed that the residual value is nil, the
purchase price is Dfl. 15 000 in each case.
In column 3 the complementary costs, which were made
at different times, are discounted (for comparison and
addition) by correcting the time difference. The expenses
for the complementary costs should also be made
comparable with the expenses for the purchase of the
analytical instrument.
Therefore, all the costs mentioned above should be
converted to the beginning of the first year (the moment
of purchase). Discounting the complementary costs
against an interest loss of 10% takes place as follows. The
cash value of the complementary costs after various
periods of use are:
One year Dfl. 12 000/1" 10 Dfl. 10 909
Two years Dfl. 10 909 + 13 000/1.10" 1" 10
Dfl. 21 653
Three years Dfl. 21 653 + 14 500/1"101.10 1.10
Dfl. 32 547
Four years Dfl. 32 547 + 17 000/1.10l’10rl’10rl’10
Dfl. 44 158
Five years Dfl. 44 158 + 20 000/
1.10r1"10 1.10r1"10 1.10r
Dfl. 56 577
In column 4 the total costs from a period of use ofone to
five years are obtained by adding the cash value of the
complementary costs (column 3) to the purchase priceF. R. Hindriks et al. Lifetime analysis of clinical laboratory instruments
(column 2). In the investment model the arithmetic
assumption is made that the products have been
delivered by the end of the year. If the analysis
instrument is used for a period ofone year, then the total
amount- Dfl. 25 909- has to be carried to the end of the
year (multiplied by the interest loss of 10%). If the
analysis instrument is used for a period oftwo years, then
the total amount- Dfl. 36 653- must be equally divided
over two years with the aid of the calculation of annuity:
Cash value of the total costs -it Ann[n] 10 Cash value
of the annual costs.
The annuity after n years ofuse with an interest of 10% is
represented by the annotation Ann[n] 10 obtained from
annuity tables. The amounts shown in column 4 are
converted into the cash value of the annual costs as
follows. After a period of use of:
One year Dfl. 25 909
Two years Dfl. 36 653
Three years Dfl. 47 547
Four years Dfl. 59 158
Five years Dfl. 71 577
1.100000 Dfl. 28 500
0.576190 Dfl. 21 119
0.402115 Dfl. 19 119
0.315471 Dfl. 18663
0.263797 Dfl. 18 882
The cost prices per unit product (test or request) shown
in column 5 are subsequently obtained by dividing by the
production quantities (1000 units per year).
In this example the cost price appears to be minimal with
a period of use of four years. From the average annual
costs related to this the debits (see table 2), can be
calculated. The total costs per year amount to Dfl. 18 663
and are shown in column 2. The annual costs, less the
complementary costs from column 3, result in the total
amount available for interest and depreciation and are
given in column 4. Finally, the latter amount less the
interest (10%) over the book value at the beginning ofthe
relevant year from column 5, results in the depreciation in
that year, as shown in column 6.
This example may seem rather complicated, but is easy to
adapt. In the first place the residual value ofan analytical
instrument is not usually nil at the end of its economic
lifetime (the machine can often be traded-in). In this
calculation the residual value can be taken up by
applying the difference between the purchase price and
cash price of the residual value at the end of the relevant
year instead of the total purchase price (see table 1,
column 2).
Secondly, there is a possibility that during the use of an
analytical instrument an alternative instrument, which
can carry out clinical chemistry tests for a lower price,
will come onto the market.
This will reduce the economic lifetime of the analytical
instrument purchased the existing instrument having
been replaced. The most suitable moment to replace the
instrument- with regard to economics can be calcu-
lated with the investment model.
Thirdly, there are usually several alternative machines
available and the model can be used to compare the
various options.
Assuming that two years after the analytical instrument
has been put to use, a new instrument becomes available
which is capable of achieving the desired production
quantities of 1000 units per year for a total amount ofDfl.
16 000, then the cost price per unit is Dfl. 16"00 with the
new instrument as against Dfl. 18"66 with the existing
instrument.
The complementary costs in the fourth year of use of the
original instrument are Dfl. 17000; the value of the
activities is, however, Dfl. 16 000 (it is possible to carry
out clinical chemistry tests for this price using the new
instrument). Therefore, the value of the activities of the
existing analysis instrument is negative (in this case
minus Dfl. 1000). If the same reasoning is applied to the
third year of use, it appears that the performance of the
existing instrument is positive (in this case Dfl. 16 000-
Dfl 14 500 Dfl. 1500). As it is still assumed that the
residual value is nil, it would seem to be worthwhile from
an economic point of view, to replace the existing
instrument with the alternative instrument at the end of
its third year of use. By doing this there is a loss of book
value ofDfl. 1511 (the part not yet debited). Through the
availability of a more economically worthwhile alterna-
tive, the economic lifetime of the existing instrument has
decreased from four to three years.
Application of the model
The calculations in the investment model can be carried
out with the aid of a microcomputer running a spread-
sheet program. The application program is based on
Lotus 1-2-3 and is suitable for use on an IBM-compatible
microcomputer with an internal memory of at least
384 kB, MS/DOS operating system.
Table 2. Calculation ofthe debits and interest in the case ofa known economic lifetime and associated annual costs. All prices shown are in
Dutch guilders. (See textfor details.)
Debit
Annual Complementary Depreciation (% of
Year costs costs and interest Interest purchase price)
(1) (2) (3) (4) (5) (6)
18663 12000 6663 1500 5163 (34"4%)
2 18 663 13 000 5663 984 4679 (31"2%)
3 18663 14 500 4163 516 3647 (24"3%)
4 18663 17000 1663 152 1511 (10"1%)
Total 74 652 56 500 18 152 3152 15 000 (100"0%)
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Average sum per year (using one currency), in which the
capital value of an investment project can be deduced
through the calculation of the market value.
Book value
The value of a means of production according to the
financial administration at the end of a year’s use.
Complementary costs
All costs, apart from depreciation and interest costs,
which can be directly attributed to the performance ofan
analysis instrument which is in production.
Economic lifetime
The length of time that it is economically worthwhile to
use an instrument.
Fixed assets
Capital purchases from which the application is attri-
buted to successive production processes. The plusses
and minusses are divided over the successive production
processes and usually over several financial years. Fixed
assets are often called ’long-lasting means ofproduction’.
Floating assets
Capital purchases, in contrast to fixed assets, in which
investments are made for only short periods- not more
than one year. Floating assets are often called ’floating
means of production’.
Investment project
The total investment in long-lasting means ofproduction,
with all additional investments in floating means of
production.
Market (cash) value
Costs which have been reduced from the time they were
made to an earlier point in time (discounting).
Residual value
The value of a means of production at the end of its last
year of use.
Technical lifetime
The length of time that an instrument is technically
capable of performing the activities for which it wa,
purchased.
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